Biomay has pioneered recombinant allergens. Our prime objective is to develop innovative solutions for the diagnosis and therapy of type 1 allergies, using novel materials and cutting-edge technologies. To ensure continuous innovation Biomay is offering cooperation opportunities to academic experts in the fields of allergology and vaccination.
If you think that your research subject (material or technology) could fit our objectives, and you are interested to cooperate with an innovative company, we would appreciate to hear from you. We are flexible with respect to the form of cooperation, which should fit your and our needs, and could range from a license to a full partnership.
Initial information
To enable us to undertake a basic evaluation of the commercial potential of your material or technology we ask you to provide us with initial information by filling in the questionnaire below as far as you can.
Your information will be treated in strict confidence and will be used for the sole purpose of our internal evaluation. If you prefer, we are also happy to sign a non disclosure agreement.
Questionnaire (right-click to download)
(please fill in and send back to info@biomay.com)
